Dexter Jin, Ph.D. from Foundation Medicine will Address Genetic Sequencing at Virtual Dialogue

Chondrosarcoma CS Foundation, Inc.
Virtual Dialogue 3: Taking Charge of Your Care
Third International Virtual Dialogue (VIA Zoom)
Tuesday, September 14, 2021
7:30PM – 9:00PM (Eastern Standard Time / New York)

The Chondrosarcoma CS Foundation, Inc. will host its Third International Forum / Virtual Dialogue featuring a panel of Chondrosarcoma survivors and prominent experts to examine new technologies, medications, and clinical trials, as well as providing information to help Chondrosarcoma patients make informed decisions to take charge of their care.

Dexter Jin, Ph.D.; is the senior scientist on the Cancer Genomics Research team at Foundation Medicine in Cambridge, MA. He did his doctoral work at the Massachusetts Institute of Technology, where I previously focused on understanding the invasive transition of breast cancers. At Foundation Medicine Dr Jin is on the Cancer Genomics Research team, where he uses FMI’s database of over 400,000 patient profiles for biomarker development and to better understand the genomics of rare cancers.

Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient’s unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials. Foundation Medicine’s molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer.

Dr Jin will discuss the benefits of genetic sequencing and how the identification of biomarkers can assist in the care and outcome of treating Chondrosarcoma.

Join Us for This Very Informative Event